Abstract
Current developmental neurotoxicity (DNT) testing in animals faces major limitations, such as high cost and time demands as well as uncertainties in their methodology, evaluation and regulation. Therefore, the use of human-based 3D in vitro systems in combination with high-content image analysis (HCA) might contribute to DNT testing with lower costs, increased throughput and enhanced predictivity for human hazard identification. Human neural progenitor cells (hNPCs) grown as 3D neurospheres mimic basic processes of brain development including hNPC migration and differentiation and are therefore useful for DNT hazard identification. HCA of migrated neurospheres creates new challenges for automated evaluations because it encompasses variable cell densities, inconsistent z-layers and heterogeneous cell populations. We tackle those challenges with our Omnisphero software, which assesses multiple endpoints of the ‘Neurosphere Assay.’ For neuronal identification, Omnisphero reaches a true positive rate (TPR) of 83.8 % and a false discovery rate (FDR) of 11.4 %, thus being comparable to the interindividual difference among two researchers (TPR = 94.3, FDR = 11.0 %) and largely improving the results obtained by an existing HCA approach, whose TPR does not exceed 50 % at a FDR above 50 %. The high FDR of existing methods results in incorrect measurements of neuronal morphological features accompanied by an overestimation of compound effects. Omnisphero additionally includes novel algorithms to assess ‘neurosphere-specific’ endpoints like radial migration and neuronal density distribution within the migration area. Furthermore, a user-assisted parameter optimization procedure makes Omnisphero accessible to non-expert end users.
Similar content being viewed by others
References
Alépée N, Bahinski A, Daneshian M, Wever BD, Fritsche E (2014) State-of-the-art of 3D cultures (organs-on-a-chip) in safety testing and pathophysiology. Altex 31:441–477. doi:10.14573/altex1406111
Anderl JL, Redpath S, Ball AJ (2009) A neuronal and astrocyte co-culture assay for high content analysis of neurotoxicity. J Vis Exp JoVE. doi:10.3791/1173
Ayuso-Sacido A, Moliterno JA, Kratovac S et al (2010) Activated EGFR signaling increases proliferation, survival, and migration and blocks neuronal differentiation in post-natal neural stem cells. J Neurooncol 97:323–337. doi:10.1007/s11060-009-0035-x
Bai X, Latecki LJ, Liu WY (2007) Skeleton pruning by contour partitioning with discrete curve evolution. IEEE Trans Pattern Anal Mach Intell 29:449–462. doi:10.1109/TPAMI.2007.59
Bal-Price AK, Coecke S, Costa L et al (2012) Advancing the science of developmental neurotoxicity (DNT): testing for better safety evaluation. Altex 29:202–215. doi:10.14573/altex.2012.2.202
Bal-Price A, Crofton KM, Leist M et al (2015) International STakeholder NETwork (ISTNET): creating a developmental neurotoxicity (DNT) testing road map for regulatory purposes. Arch Toxicol 89:269–287. doi:10.1007/s00204-015-1464-2
Barenys M, Gassmann K, Baksmeier C et al (2016) Epigallocatechin gallate (EGCG) inhibits adhesion and migration of neural progenitor cells in vitro. Arch Toxicol. doi:10.1007/s00204-016-1709-8
Baumann J, Barenys M, Gassmann K, Fritsche E (2014) Comparative human and rat “neurosphere assay” for developmental neurotoxicity testing. Curr Protoc Toxicol 59:12.21.1–12.21.24. doi:10.1002/0471140856.tx1221s59
Baumann J, Gassmann K, Masjosthusmann S et al (2015) Comparative human and rat neurospheres reveal species differences in chemical effects on neurodevelopmental key events. Arch Toxicol. doi:10.1007/s00204-015-1568-8
Baumann J, Dach K, Barenys M et al (2016) Application of the neurosphere assay for DNT hazard assessment: challenges and limitations. Methods Pharmacol Toxicol. doi:10.1007/7653
Bellanger M, Pichery C, Aerts D et al (2013) Economic benefits of methylmercury exposure control in Europe: monetary value of neurotoxicity prevention. Environ Health 12:3. doi:10.1186/1476-069X-12-3
Bernhoft RA (2012) Mercury toxicity and treatment: a review of the literature. J Environ Public Health 2012:1–10. doi:10.1155/2012/460508
Cohen J (1968) Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit. Psychol Bull 70(4):213–220
Erkekoglu P, Baydar T (2014) Acrylamide neurotoxicity. Nutr Neurosci 17:49–57. doi:10.1179/1476830513Y.0000000065
Fritsche E, Alm H, Baumann J et al (2015) Literature review on in vitro and alternative developmental neurotoxicity (DNT) testing methods. EFSA Support Publ 778:1–186. doi:10.2903/sp.efsa.2015.EN-778
Gassmann K, Abel J, Bothe H et al (2010) Species-specific differential AhR expression protects human neural progenitor cells against developmental neurotoxicity of PAHs. Environ Health Perspect 118:1571–1577. doi:10.1289/ehp.0901545
Goldman LR, Koduru S (2000) Chemicals in the environment and developmental toxicity to children: a public health and policy perspective. Environ Health Perspect 108(Suppl):443–448. doi:10.2307/3454535
Grandjean P, Landrigan PJ (2014) Neurobehavioural effects of developmental toxicity. Lancet Neurol 13:330–338. doi:10.1016/S1474-4422(13)70278-3
Harrill JA, Freudenrich TM, Machacek DW, Stice SL, Mundy WR (2010) Quantitative assessment of neurite outgrowth in human embryonic stem cell-derived hN2 cells using automated high-content image analysis. Neurotoxicology 31:277–290. doi:10.1016/j.neuro.2010.02.003
Harrill JA, Freudenrich TM, Robinette BL, Mundy WR (2011a) Comparative sensitivity of human and rat neural cultures to chemical-induced inhibition of neurite outgrowth. Toxicol Appl Pharmacol 256:268–280. doi:10.1016/j.taap.2011.02.013
Harrill JA, Robinette BL, Mundy WR (2011b) Use of high content image analysis to detect chemical-induced changes in synaptogenesis in vitro. Toxicol In Vitro 25:368–387. doi:10.1016/j.tiv.2010.10.011
Jennings P (2015) The future of in vitro toxicology. Toxicol In Vitro 29:1217–1221. doi:10.1016/j.tiv.2014.08.011
Kakita A, Inenaga C, Sakamoto M, Takahashi H (2002) Neuronal migration disturbance and consequent cytoarchitecture in the cerebral cortex following transplacental administration of methylmercury. Acta Neuropathol 104:409–417. doi:10.1007/s00401-002-0571-3
Kalkbrenner AE, Schmidt RJ, Penlesky AC (2014) Environmental chemical exposures and autism spectrum disorders: a review of the epidemiological evidence. Amy Curr Probl Pediatr Adolesc Health Care 44:277–318. doi:10.1016/j.cppeds.2014.06.001.Environmental
Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33(1):159–174
McDonald ME, Paul JF (2010) Timing of increased autistic disorder cumulative incidence. Environ Sci Technol 44:2112–2118. doi:10.1021/es902057k
Moors M, Cline JE, Abel J, Fritsche E (2007) ERK-dependent and -independent pathways trigger human neural progenitor cell migration. Toxicol Appl Pharmacol 221:57–67. doi:10.1016/j.taap.2007.02.018
Moors M, Rockel TD, Abel J et al (2009) Human neurospheres as three-dimensional cellular systems for developmental neurotoxicity testing. Environ Health Perspect 117:1131–1138. doi:10.1289/ehp.0800207
NRC (2007) Toxicity testing in the 21st century: a vision and a strategy. The National Academies Press, London, pp 1–216
Ogawa B, Ohishi T, Wang L et al (2011) Disruptive neuronal development by acrylamide in the hippocampal dentate hilus after developmental exposure in rats. Arch Toxicol 85:987–994. doi:10.1007/s00204-010-0622-9
Park HR, Kim M-S, Kim SJ et al (2010) Acrylamide induces cell death in neural progenitor cells and impairs hippocampal neurogenesis. Toxicol Lett 193:86–93. doi:10.1016/j.toxlet.2009.12.015
Puehringer D, Orel N, Lüningschrör P et al (2013) EGF transactivation of Trk receptors regulates the migration of newborn cortical neurons. Nat Neurosci 16:407–415. doi:10.1038/nn.3333
Ryan KR, Sirenko O, Parham F et al (2016) Neurite outgrowth in human induced pluripotent stem cell-derived neurons as a high-throughput screen for developmental neurotoxicity or neurotoxicity. Neurotoxicology. doi:10.1016/j.neuro.2016.02.003
Stang A, Pohlabeln H, Muller KM, Jahn I, Giersiepen K, Jockel KH (2006) Diagnostic agreement in the histopathological evaluation of lung cancer tissue in a population-based case-control study. Lung Cancer 52(1):29–36. doi:10.1016/j.lungcan.2005.11.012
Tsuji R, Crofton KM (2012) Developmental neurotoxicity guideline study: issues with methodology, evaluation and regulation. Congenit Anom 52:122–128. doi:10.1111/j.1741-4520.2012.00374.x
Vinic M, Box C, Zimmermann M, Eccles SA (2013) Target identification and validation in drug discovery target identification and validation. Drug Discov 986:187–214. doi:10.1007/978-1-62703-311-4
Wang C, Gui C-P, Liu H-K, Zhang D, Mosig A (2013) An image skeletonization-based tool for pollen tube morphology analysis and phenotyping. J Integr Plant Biol 55:131–141. doi:10.1111/j.1744-7909.2012.01184.x
Weiss B (1988) Neurobehavioral toxicity as a basis for risk assessment. Trends Pharmacol Sci 9:59–62. doi:10.1016/0165-6147(88)90118-6
Wilson MS, Graham JR, Ball AJ (2014) Multiparametric high content analysis for assessment of neurotoxicity in differentiated neuronal cell lines and human embryonic stem cell-derived neurons. Neurotoxicology 42:33–48. doi:10.1016/j.neuro.2014.03.013
Funding
This project was funded by the DFG through the research training group 1033 and by the German Ministry for Education and Research (16V0899).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Martin R. Schmuck and Thomas Temme: shared first authorship. Axel Mosig and Ellen Fritsche: shared senior authorship.
Open source software (under the GPLv3 license) is available at https://www.omnisphero.com.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Schmuck, M.R., Temme, T., Dach, K. et al. Omnisphero: a high-content image analysis (HCA) approach for phenotypic developmental neurotoxicity (DNT) screenings of organoid neurosphere cultures in vitro. Arch Toxicol 91, 2017–2028 (2017). https://doi.org/10.1007/s00204-016-1852-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00204-016-1852-2